易明医药(002826) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥179,390,590.62, representing a 16.02% increase compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2021 was ¥6,955,330.26, a significant increase of 78.21% year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥7,375,415.08, up by 51.34% compared to the same period last year[4] - The basic earnings per share for Q3 2021 was ¥0.04, a 100% increase compared to the same period last year[4] - Total operating revenue for Q3 2021 reached ¥518,143,668.07, an increase of 28.5% compared to ¥403,325,127.76 in Q3 2020[22] - Net profit for Q3 2021 was ¥17,172,369.51, slightly up from ¥17,092,345.30 in Q3 2020, indicating a marginal growth of 0.5%[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥804,910,710.40, a decrease of 11.36% from the end of the previous year[4] - The company's total assets decreased to ¥804,910,710.40 as of September 30, 2021, down from ¥908,087,426.76 at the end of 2020, representing a decline of 11.4%[20] - Current assets totaled ¥329,196,257.00, a decrease of 26.9% from ¥450,252,514.19 at the end of 2020[20] - The total liabilities decreased significantly, with contract liabilities down by 56.39% to CNY 20.66 million, indicating improved revenue recognition[10] - The total liabilities decreased to ¥112,735,784.35 from ¥220,940,937.86, a reduction of 48.9%[21] - Total liabilities amounted to CNY 220,940,937.86, a slight decrease of CNY 168,874.63 compared to the previous period[30] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥69,249,556.94, an increase of 64.37%[4] - The net cash flow from operating activities increased to CNY 69,249,556.94, compared to CNY 42,129,411.90 in the same period last year[26] - Total cash inflow from operating activities was CNY 965,164,381.49, up from CNY 616,374,344.36 in the previous year[25] - Total cash outflow from operating activities was CNY 895,914,824.55, compared to CNY 574,244,932.46 in the same period last year[25] - The net cash flow from investment activities was negative at CNY -55,205,676.97, worsening from CNY -16,900,961.83 in the previous period[26] - The company experienced a net decrease in cash and cash equivalents of CNY -45,112,907.25 during the period[26] Shareholder Information - The total number of common shareholders at the end of the reporting period is 20,704[13] - The top shareholder, Gao Fan, holds 26.66% of shares, totaling 50,971,482 shares, with 20,485,535 shares pledged[13] - The top ten shareholders hold a combined 56.66% of the shares, indicating significant ownership concentration[13] - The company repurchased and canceled 490,125 restricted stock units due to not meeting performance targets, reducing total shares from 191,769,000 to 191,190,375[17] Research and Development - Research and development expenses surged by 180.10% to CNY 6.93 million, up from CNY 2.47 million in the prior year, reflecting increased investment in R&D projects[10] - The company reported R&D expenses of ¥6,925,510.60 for Q3 2021, significantly higher than ¥2,472,500.96 in Q3 2020, reflecting an increase of 179.5%[22] Acquisitions and Investments - The company acquired 51% of Inner Mongolia Bostai Enterprise Management Service Co., Ltd. for 30.6 million RMB, becoming its controlling shareholder[17] - The company reported a significant increase in goodwill by 375.70% to CNY 36.47 million, primarily due to the acquisition of a 51% stake in Inner Mongolia Bostai[10] - The company has entrusted 21 million RMB in financial management products, with expected returns of 3.20% to 2.85%[16] - The company has a total of 10 million RMB in entrusted financial management with no overdue amounts[16] Governance and Compliance - The company’s board and supervisory board were re-elected on September 13, 2021, completing the governance transition[17] - The third quarter report was not audited, indicating preliminary financial results[32] - The company did not make retrospective adjustments for prior periods under the new standards[31] - The company has adopted new leasing standards starting from 2021, with no significant impact on financial status or cash flow[31] Dividends - A cash dividend of 0.80 RMB per 10 shares was distributed, totaling 15,295,230 RMB[17]